Catalent Pharma Solutions, a global drug delivery technology and advanced supply solutions company, has announced an expansion of its controlled release drug manufacturing facility in Winchester, Ky. Catalent will invest nearly $35 million to expand the 100,000-square-foot facility by almost 80,000 square feet of modern manufacturing space, and will add as many as 90 new employees.

Opened in 1992, Catalent's Winchester facility focuses on advanced oral controlled-release drug formulation and manufacturing, and has launched over 100 products for Catalent's pharmaceutical and consumer health customers.

"As with Winchester, Catalent continues to invest to meet the most critical needs of the industry, including recently announced inhalation facility expansion in North Carolina, our recently completed biologics expansion in Wisconsin and our two new ventures in China, which will focus on softgel technologies and clinical trial supplies," said John Chiminski, Catalent president and chief executive officer.